Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection
- 1 January 1990
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 4 (1) , 20-23
- https://doi.org/10.1002/bmc.1130040103
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Improved method for the determination of 4′-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administrationEuropean Journal of Clinical Pharmacology, 1986
- Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patientsEuropean Journal of Cancer and Clinical Oncology, 1985
- Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicinEuropean Journal of Cancer and Clinical Oncology, 1984
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Pharmacokinetics of 4′-epi-doxorubicin in manInvestigational New Drugs, 1983
- Analysis of adriamycin and adriamycinol in micro volumes of rat plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Determination of 4′-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Extraction of Anthracyclines from Biological Fluids for HPLC EvaluationJournal of Liquid Chromatography, 1980